← Back to headlines
Pulse Biosciences slips despite Q4 beat after deal to sell shares
Pulse Biosciences saw its stock decline despite reporting better-than-expected fourth-quarter earnings, following a deal to sell shares.
20 Feb, 15:22 — 20 Feb, 15:22
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
China leaves benchmark lending rates unchanged as Beijing signals tolerance for stronger yuan
6m ago
Bitcoin Falls Over 5% Amid Tariff Tensions
7m ago
Tennant misses top-line and bottom-line estimates; introduces FY26 outlook
26m ago
Elliott woos shareholders backing Toyota Industries buyout, Reuters reports
26m ago